Immix Biopharma Inc (IMMX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$13.91+0.58%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IMMX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 21.6 | 16.3 | 11.3 | 8.7 | 4.2 | 0.1 | 0.2 |
| Operating Income | (41.8) | (30.0) | (22.7) | (16.1) | (8.2) | (1.4) | (0.5) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | 0.0 | 0.2 | 0.1 |
| Interest & Investment Income | 1.9 | 0.6 | 1.0 | 0.6 | — | — | — |
| Other Non-Operating Income / Expenses | 1.9 | 0.6 | 1.0 | 0.6 | (0.0) | (23.0) | (0.7) |
| EBT, Incl. Unusual Items | (39.9) | (29.4) | (21.7) | (15.6) | (8.2) | (24.4) | (1.1) |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Minority Interest | — | — | (0.1) | (0.2) | — | — | — |
| Net Income | (39.9) | (29.4) | (21.6) | (15.4) | (8.2) | (24.4) | (1.1) |
| Per Share | |||||||
| Basic EPS | (0.63) | (0.89) | (0.76) | (0.89) | (0.59) | (6.64) | — |
| Diluted EPS | (0.63) | (0.89) | (0.76) | (0.89) | (0.59) | — | — |
| Basic Weighted Avg Shares | 63.8 | 33.0 | 28.3 | 17.3 | 13.9 | 3.7 | — |
| Diluted Weighted Avg Shares | 63.8 | 33.0 | 28.3 | 17.3 | 13.9 | — | — |
| Supplemental | |||||||
| EBIT | (41.8) | (30.0) | (22.7) | (16.1) | (8.2) | (1.4) | (0.5) |
| Effective Tax Rate | — | — | — | -0.2% | -0.1% | -0.0% | -1.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.